Lymphomas
📧 Sign up to get email alerts when something new happens for Lymphomas.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of bortezomib and clofarabine in adults with relapsed solid tumors has been completed. The listed…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors [Phase 1]
Phase 1 trial update on entinostat in pediatric patients with recurrent or refractory solid tumors, completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of alobresib (GS-5829) in adults with advanced solid t…
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: tTF-NGR Phase I Study [Phase 1]
Phase I trial update for tTF-NGR in malignant solid tumors and lymphomas has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Anti-CD19 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphomas [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating anti-CD19 CAR-T cells for relapsed or refractory acute lymphoblastic leukemia and lymphomas.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction [Phase 1]
Phase 1 trial of belinostat in patients with solid tumors and lymphomas across varying hepatic dysfunction shows completed status with resul…
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]
A Phase I/IIa open-label dose-escalation and expansion study of oral TSR-011 in patients with advanced solid tumors and lymphomas has comple…
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas [Phase 1]
A Phase 1 trial of alisertib (MLN8237) in adult East Asian participants with advanced solid tumors or lymphomas has completed with posted re…
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: This is a Phase 1 Study of Eribulin Mesylate in Pediatric Participants With Recurrent or Refractory Solid Tumors (Excluding [Central Nervous System] CNS), Including Lymphomas [Phase 1]
Phase 1 study of eribulin mesylate in pediatric participants with recurrent or refractory solid tumors (excluding CNS) and lymphomas complet…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Post Transplant Donor Lymphocyte Infusion [Phase 2]
Phase 2 clinical trial update for post-transplant donor lymphocyte infusion; the study is terminated with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation. [NA]
A completed clinical trial assessing the impact of varying DMSO concentrations on hematopoietic recovery after autologous hematopoietic stem…
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas [Phase 1, Phase 2]
Phase 1/2 trial evaluating vorinostat with pegylated liposomal doxorubicin in relapsed or refractory lymphomas; the study is terminated with…